JP2004523557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004523557A5 JP2004523557A5 JP2002567298A JP2002567298A JP2004523557A5 JP 2004523557 A5 JP2004523557 A5 JP 2004523557A5 JP 2002567298 A JP2002567298 A JP 2002567298A JP 2002567298 A JP2002567298 A JP 2002567298A JP 2004523557 A5 JP2004523557 A5 JP 2004523557A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutical composition
- composition according
- alkyl
- pyrrolidone compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27098701P | 2001-02-23 | 2001-02-23 | |
| PCT/US2002/005189 WO2002067931A1 (en) | 2001-02-23 | 2002-02-22 | Treatment of tics, tremors and related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004523557A JP2004523557A (ja) | 2004-08-05 |
| JP2004523557A5 true JP2004523557A5 (enExample) | 2005-12-22 |
Family
ID=23033711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567298A Pending JP2004523557A (ja) | 2001-02-23 | 2002-02-22 | チック、振せん、および関連疾患の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040116505A1 (enExample) |
| EP (1) | EP1379236A4 (enExample) |
| JP (1) | JP2004523557A (enExample) |
| AU (1) | AU2002245486B2 (enExample) |
| CA (1) | CA2438930A1 (enExample) |
| WO (1) | WO2002067931A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60218193T2 (de) * | 2001-10-08 | 2007-11-22 | Ucb S.A. | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia |
| US7427601B2 (en) * | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
| US20070259859A1 (en) * | 2006-05-04 | 2007-11-08 | De Bruin Natasja M W J | Muscarinic agonists to treat impulse control disorders |
| AU2007247231B2 (en) * | 2006-05-04 | 2012-05-31 | Solvay Pharmaceuticals B.V. | Muscarinic agonists to treat impulse control disorders |
| EP2346500B1 (en) | 2008-10-16 | 2017-05-17 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| EP2533645B1 (en) * | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| CA2807505A1 (en) | 2010-08-24 | 2012-03-01 | The Children's Hospital Of Philadelphia | Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| CN103073477A (zh) * | 2013-01-24 | 2013-05-01 | 吉林三善恩科技开发有限公司 | 以3,4-二羟基苯甲酸为前驱体的吡拉西坦药物共晶及其制备方法 |
| CN103044307A (zh) * | 2013-01-24 | 2013-04-17 | 吉林三善恩科技开发有限公司 | 以2,4-二羟基苯甲酸为前驱体的吡拉西坦药物共晶及其制备方法 |
| CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| US11219617B2 (en) | 2014-05-30 | 2022-01-11 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating autism |
| WO2015184542A1 (en) * | 2014-06-02 | 2015-12-10 | Ketogen Inc. | Compounds for the treatment of seizures and other central nervous system disorders and conditions |
| EA034167B8 (ru) | 2015-05-22 | 2021-04-27 | Эйджинбайо, Инк. | Фармацевтические композиции леветирацетама пролонгированного высвобождения |
| WO2017044491A1 (en) | 2015-09-08 | 2017-03-16 | The Children's Hospital Of Philadelphia | Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22q syndrome |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4355027A (en) * | 1977-11-02 | 1982-10-19 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering piracetam and choline |
| CH657527A5 (de) * | 1980-02-13 | 1986-09-15 | Ciba Geigy Ag | Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist. |
| GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| JPH0829140B2 (ja) * | 1987-04-17 | 1996-03-27 | 開成工業株式会社 | 末▲梢▼循環機能障害診断用皮フ温測定装置 |
| US6107492A (en) * | 1998-05-08 | 2000-08-22 | Ucb, S.A. | Process for the preparation of levetiracetam |
| CA2392879C (en) * | 1999-12-01 | 2005-03-29 | Ucb, S.A. | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
-
2002
- 2002-02-22 WO PCT/US2002/005189 patent/WO2002067931A1/en not_active Ceased
- 2002-02-22 AU AU2002245486A patent/AU2002245486B2/en not_active Ceased
- 2002-02-22 CA CA002438930A patent/CA2438930A1/en not_active Abandoned
- 2002-02-22 JP JP2002567298A patent/JP2004523557A/ja active Pending
- 2002-02-22 US US10/468,937 patent/US20040116505A1/en not_active Abandoned
- 2002-02-22 EP EP02713649A patent/EP1379236A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5667684B2 (ja) | 関節炎の治療方法 | |
| RU2006116887A (ru) | Производные n-[гетероарил(пиперидин-2-ил)метил]бензамида, способ получения указанных соединений и их применение в терапии | |
| RU94044671A (ru) | Применение непептидных антагонистов рецептора тахикинина | |
| CA2528160A1 (en) | Use of 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine for neuronal regeneration and functional recovery | |
| TW200621249A (en) | Substituted amide beta secretase inhibitors | |
| NO20081772L (no) | Ikke-basiske antagonister av melaninkonsentrerende hormon-reseptor-1 | |
| HUP0204526A2 (hu) | 2-Oxo-1-pirrolidin-származékok, eljárás előállításukra és alkalmazásuk | |
| CN102387704A (zh) | S1p5受体的激动剂和拮抗剂，和其用法 | |
| TW200607807A (en) | Macrocyclic beta-secretase inhibitors | |
| JP2006507220A5 (enExample) | ||
| TNSN04246A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
| JP2005511698A5 (enExample) | ||
| JP2006503850A5 (enExample) | ||
| US20040116505A1 (en) | Treatment of tics, tremors and related disorders | |
| RU2007128085A (ru) | Соли четвертичного аммония в качестве антагонистов м3 | |
| AU2002245486A1 (en) | Treatment of tics, tremors and related disorders | |
| JP2022527618A5 (enExample) | ||
| RU2005122615A (ru) | Соединения n-(индолэтил)циклоамина | |
| JP2008538583A5 (enExample) | ||
| MXPA05010614A (es) | Uso de derivados de 10-hidroxi-10,11-dihidrocarbamazepina para el tratamiento de trastornos afectivos. | |
| JPH06500099A (ja) | Ｃｎｓ疾病の処置におけるヘテロ環状アミノ―アルコール化合物の使用 | |
| EP1201240A3 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
| CA2534634A1 (en) | Azolidinecarbonitriles and their use as dpp-iv inhibitors | |
| JP2006510659A5 (enExample) | ||
| JP2005501108A (ja) | 神経変性治療におけるネフィラセタムの使用 |